Trading Profile: Egalet Corporation, a specialty pharmaceutical company, engages in developing, manufacturing, and commercializing medicines for patients with acute and chronic pain. It has licensed two approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; and OXAYDO, an immediate-release oxycodone product formulated to deter abuse via snorting for the management of acute and chronic moderate to severe pain where an opioid is appropriate. The company also develops a pipeline of clinical-stage, opioid-based product candidates that are specifically designed to deter abuse by physical and chemical manipulation using its proprietary Guardian Technology. Its product candidates include Egalet-001 and Egalet-002 that are abuse-deterrent, extended-release, oral formulations for the treatment of moderate and severe pain. The company has a collaboration and license agreement with Shionogi Limited to develop, manufacture, and commercialize abuse-deterrent hydrocodone-based product candidates using its technology. Egalet Corporation was founded in 2010 and is headquartered Wayne, Pennsylvania.
»»» Detailed Company Profile & Chart
Egalet Corp current day financials: 2024-04-19 01:17:18amSymbol | Name | Purchase price | Last Price | Change | % Change |
---|---|---|---|---|---|
0.00 | |||||
Recent EGLT News from Yahoo Finance & Seeking Alpha
Older Archived News Egalet Corp
- Insider Trading Alert - ADSK, EGLT And CPE Traded By Insiders.
- Insider Trading Alert - PLOW, DST And EGLT Traded By Insiders.
- Insider Trading Alert - LOCK, CYBX And EGLT Traded By Insiders.
- Insider Trading Alert - EGLT, STFC And CVGW Traded By Insiders.
- Insider Trading Alert - SFBS, WIFI And EGLT Traded By Insiders.
- Wayne biopharm firm gets worldwide rights to experimental pain drug.
- Hedge Funds Are Betting On Egalet Corp.
- Egalet to Participate in Guggenheim Boston Healthcare Day – Life Sciences.
- Egalet Submits New Drug Application to U.S. Food and Drug Administration for ARYMOâ„¢ ER.
- Egalet Signs Agreement with Teva Pharmaceutical Industries to Commercialize SPRIX®.Load More News...